Target and Its Patented Drug(s)
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T59102 | Target Info | |||
| Target Name | Platelet-derived growth factor receptor beta (PDGFRB) | ||||
| Synonyms | Platelet-derived growth factor receptor 1; PDGFR1; PDGFR-beta; PDGFR-1; PDGFR; PDGF-R-beta; CD140b antigen; CD140b; CD140 antigen-like family member B; Beta-type platelet-derived growth factor receptor; Beta-PDGFR; Beta platelet-derived growth factor receptor | ||||
| Target Type | Successful Target | ||||
| Gene Name | PDGFRB | ||||
| Biochemical Class | Kinase | ||||
| UniProt ID | |||||
| Patent(s) and the Corresponding Patented Drug(s) | Top | ||||
|---|---|---|---|---|---|
| United States Patent and Trademark Office (USPTO) | |||||
| Patent ID | US2014275201 | ||||
| Title | The University of Texas System. Identification of Cancer Stem Cell Markers and Use of Inhibitors Thereof To Treat Cancer. | ||||
| Representative Drug(s) | D0YX2B | Drug Info | IC50 = 2 nM | [1] | |
| Patent ID | US9029386 | ||||
| Title | Inhibitors of Kinase Activity. | ||||
| Applicant(s) | Ym Biosciences Australia Pty | ||||
| Representative Drug(s) | D0AK1F | Drug Info | N.A. | [2] | |
| Patent ID | US20130137660 | ||||
| Title | Inhibitors of Kinase Activity. | ||||
| Applicant(s) | Ym Biosciences Australia Pty | ||||
| Representative Drug(s) | D0AK1F | Drug Info | N.A. | [2] | |
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jul;27(7):753-761. | ||||
| REF 2 | RET kinase inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jan;27(1):91-99. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.